R David Anderson Selected Research

R David Anderson Research Topics

13	Myocardial Infarction 10/2023 - 07/2002
10	Stroke (Strokes) 10/2023 - 09/2008
9	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 11/2017
9	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 01/2010
8	Ischemia 01/2023 - 06/2010
7	Hemorrhage 10/2023 - 06/2009
6	Heart Failure 01/2021 - 06/2010
4	Intermittent Claudication 04/2017 - 06/2002
3	Myocardial Ischemia (Ischemic Heart Diseases) 10/2018 - 10/2016
3	Peripheral Arterial Disease 04/2017 - 05/2007
3	Atherosclerosis 12/2010 - 06/2002
2	Chronic Renal Insufficiency 04/2024 - 10/2023
2	Dyslipidemias (Dyslipidemia) 01/2020 - 06/2015
2	Hypertension (High Blood Pressure) 01/2020 - 01/2019
2	Pathologic Constriction (Stenosis) 09/2018 - 09/2008
2	ST Elevation Myocardial Infarction 01/2018 - 12/2012
2	Thrombosis (Thrombus) 11/2017 - 10/2017
2	Acute Kidney Injury (Acute Renal Failure) 07/2016 - 01/2015
2	Left Ventricular Dysfunction 12/2012 - 04/2012
1	Diabetes Mellitus 09/2023
1	Hemophilia A (Haemophilia) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Bicuspid Aortic Valve Disease 09/2018
1	Aortic Valve Stenosis (Aortic Stenosis) 03/2018
1	Tachycardia (Tachyarrhythmias) 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Erectile Dysfunction 01/2018
1	Ventricular Tachycardia 10/2017
1	Coronary Thrombosis 10/2017
1	Cardiac Arrhythmias (Arrythmia) 10/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 06/2016
1	Non-ST Elevated Myocardial Infarction 03/2016
1	False Aneurysm (Pseudoaneurysm) 06/2010
1	Prolapse 06/2009
1	Hematoma 06/2009

5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 01/2018
5	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 06/2010
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2018
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2017 - 01/2017
1	Clopidogrel (Plavix)FDA Link 04/2024
1	Cytochrome P-450 CYP2C19IBA 04/2024
1	CalciumIBA 11/2021
1	NitratesIBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2018
1	AnticoagulantsIBA 11/2017
1	Aldehyde DehydrogenaseIBA 04/2017
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 10/2016
1	Hormones (Hormone)IBA 06/2015
1	MetalsIBA 02/2014
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 01/2014
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2014
1	Dihydrotachysterol (AT 10)IBA 07/2013
1	omega-Chloroacetophenone (Mace)IBA 06/2012
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2011
1	Phenobarbital (Luminal)FDA Link 12/2010
1	trandolapril (Mavik)FDA LinkGeneric 01/2010
1	Verapamil (Calan)FDA LinkGeneric 01/2010
1	HydrogelsIBA 06/2009
1	Poloxamer (Poloxamer 407)IBA 05/2007
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 06/2002

13	Therapeutics 04/2024 - 07/2002
7	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 04/2012
5	Transcatheter Aortic Valve Replacement 09/2018 - 01/2015
3	Secondary Prevention 10/2023 - 09/2008
3	Stents 11/2017 - 06/2010
2	Blood Transfusion (Blood Transfusions) 10/2023 - 07/2016
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 07/2016
2	Heart-Assist Devices 01/2018 - 10/2017
2	Percutaneous Coronary Intervention 10/2017 - 12/2012
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019
1	Intravenous Infusions 10/2018
1	Contraindications 09/2018
1	Wearable Electronic Devices 12/2017
1	Surgical Amputation (Amputations) 04/2017
1	Ambulatory Care (Outpatient Care) 06/2016
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 06/2016
1	Catheters 06/2016
1	Intramuscular Injections 11/2014
1	Drug-Eluting Stents 02/2014
1	Injections 04/2012
1	Length of Stay 06/2010
1	Decompression 06/2010
1	Carotid Endarterectomy 09/2008
1	Intra-Arterial Infusions 06/2002